Our Approach
JDRF supports development of drugs and behavioral health interventions that delay or prevent progression of eye and kidney disease and improve mental health and quality of life.
Eye and Kidney Disease
JDRF’s goal and top priority in complications is the development of eye and kidney disease treatments for people with T1D. JDRF will also opportunistically support research to improve heart disease outcomes in T1D.
Psychosocial
The challenges of living with T1D are complex, vast, and individualistic, from diagnosis and therapy confusion to emotional and physical burden, and varies by age, stage, gender and other factors. By approaching the unique issues related to a life-long journey, we are helping to reduce the significant daily burden of this disease.
Program Goals
Develop therapies that prevent, delay, or reverse the progressive decline of vision in the disease.
Develop therapies to prevent, delay, or reverse kidney function decline.
Establish psychosocial interventions that offer sustained health benefits, are scalable, and are supported by strong clinical data for broader implementation in clinical care.
Progress
Looking ahead
We are working toward the day when complications are reversed and prevented for people living with T1D.
Want to learn more? View JDRF Scientists Jonathan Rosen, Ph.D., and Jeannette Soderberg, Ph.D., below as they explain JDRF’s efforts in this area.
Drugs and Devices for Glucose Control
Making T1D easier to manage with improved technologies, like artificial pancreas systems, improved insulins, and other drugs – all with reduced disease management burden.
Cures
We don’t have cures for T1D yet, but we know what must be done to make them a reality.